Latest news for health care topics. Include medical news , health insurance , therapy and vaccine news

Saturday, December 31, 2016

Ebola struggle reaches milestone with vaccine quoting : newsobserver

This content may collect you by Lucy William

We will quote to you most important and trendy news about all kind of Vaccine of the best health sites Like : "newsobserver" and the most famous medical experts : The Editorial Board


daily : 2016-12-31 & on time : 21:50


as declared in





An Ebola vaccine gets beyond the research stage


An Ebola vaccine gets beyond the research stage
image uploaded by "newsobserver" site
4:46 North Carolina coach Roy Williams: "Their coach did a much better job" Pause2:28 UNC's Trubisky reflects on the Tar Heels' loss to Stanford in the Sun Bowl and the fumble1:46 Joel Berry on Tar Heels' loss to Georgia Tech1:39 UNC's Switzer heads into workouts for NFL draft2:46 Fedora: 'Our guys fought all the way to the end'2:27 UNC academic scandal explained0:30 UNC's Roy Williams talks about his ailing knees5:18 Roy Williams on win over Northern Iowa and the NCAA investigation1:19 North Carolina coach Roy Williams on his recovery from knee surgery
about the details read more from here


Ebola struggle reaches milestone with vaccine


Ebola struggle reaches milestone with vaccine
image uploaded by "sandiegouniontribune" site
Efforts to defeat Ebola have reached a milestone with a new vaccine that so far appears to be 100 percent effective against Ebola Zaire, the most threatening strain of the deadly virus.And lessons learned from developing that vaccine could help public-health officials fight similar hemorrhagic fever infections, researchers said.The frightening Ebola epidemic of 2014, located in the West African countries of Sierra Leone, Liberia and Guinea, was the worst outbreak ever reported.
about the details read more from here


Final trial results confirm Ebola vaccine provides high protection against disease


Final trial results confirm Ebola vaccine provides high protection against disease
image uploaded by "who" site
Final trial results confirm Ebola vaccine provides high protection against disease23 December 2016 | GENEVA - An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet.The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11 841 people in Guinea during 2015.
about the details read more from here


Ebola vaccine is safe and effective, scientists declare after trials


Ebola vaccine is safe and effective, scientists declare after trials
image uploaded by "theguardian" site
Results from research conducted in west Africa indicate the drug will drastically reduce the severity of further outbreaksA vaccine for Ebola which has completed successful trials in Guinea and Sierra Leone means the virus should never again be able to wreak the havoc it did during the recent epidemic in west Africa, say scientists.More than 11,000 people died in the outbreak, which began unnoticed in December 2013 and spread across the region, infecting at least 28,600 people and triggering a global response, including a race to get an effective vaccine tested and into use.Final results for the vaccine that was rushed into trials in Guinea and later Sierra Leone show that it was highly effective against one of the most lethal known pathogens in existence.
about the details read more from here


An experimental vaccine against Ebola is 100 percent effective in clinical trials


An experimental vaccine against Ebola is 100 percent effective in clinical trials
image uploaded by "robesonian" site
LOS ANGELES (AP)— Wednesday AHF lauded the publication of clinical trial results in the journal Lancet which showed 100 percent efficacy in preventing Ebola virus infection among study participants who received an experimental vaccine in Sierra Leone and Guinea.An international consortium of scientists set out to test the effectiveness of a candidate vaccine known as rVSV-ZEBOV in an open-label, cluster-randomized trial involving over 9,000 participants during the Ebola outbreak in West Africa in 2015.Of 3,775 participants who received the vaccine immediately after being placed in a study group, zero patients developed Ebola 10 days or more after vaccination.
about the details read more from here


To follow all the new news about Vaccine

No comments:

Post a Comment